UGT1A4 Activators represent a category of chemical compounds that specifically target and modulate the activity of the UGT1A4 enzyme. UGT1A4 belongs to the UDP-glucuronosyltransferase (UGT) superfamily of enzymes, which play a critical role in drug metabolism and the biotransformation of various endogenous and exogenous compounds. UGT1A4, in particular, is responsible for the glucuronidation of a wide range of substrates, including drugs, hormones, and xenobiotics, through the conjugation of glucuronic acid to these molecules. This enzymatic process is crucial for the detoxification and elimination of substances from the body, as it enhances their water solubility and facilitates their excretion via the kidneys.
UGT1A4 activators are compounds that interact with the UGT1A4 enzyme, typically at the molecular level, to stimulate its enzymatic activity. This activation can occur through various mechanisms, such as binding to specific allosteric sites on the enzyme, enhancing the recruitment of co-factors, or stabilizing the enzyme's active conformation. By promoting UGT1A4 activity, these activators can have a profound impact on the metabolism and clearance of its substrates, influencing the overall pharmacokinetics and disposition of drugs and other compounds in the body. Understanding and manipulating UGT1A4 activation is of great interest in the field of pharmacology and toxicology, as it can provide insights into drug-drug interactions and individual variability in drug response. It's important to note that this description focuses solely on the molecular and pharmacological aspects of UGT1A4 activators.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin activates UGT1A4 by inducing its expression via the pregnane X receptor (PXR). | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
Clofibrate induces UGT1A4 activity by peroxisome proliferator-activated receptor (PPAR) agonism. | ||||||
Oltipraz | 64224-21-1 | sc-205777 sc-205777A | 500 mg 1 g | $286.00 $622.00 | ||
Oltipraz activates UGT1A4 by inducing its expression, potentially through Nrf2 signaling. | ||||||
5-Aminosalicylic acid | 89-57-6 | sc-202890 | 5 g | $27.00 | 4 | |
This compound activates UGT1A4 by upregulating its expression, though the exact pathway is unclear. | ||||||
Ethynyl Estradiol | 57-63-6 | sc-205318 sc-205318A | 100 mg 500 mg | $20.00 $29.00 | 3 | |
Ethynyl Estradiol activates UGT1A4 by hormonal modulation, possibly involving estrogen receptors. | ||||||
Pregnenolone | 145-13-1 | sc-204860 sc-204860A sc-204860B sc-204860C | 5 g 25 g 100 g 500 g | $87.00 $148.00 $347.00 $1122.00 | ||
Pregnenolone increases UGT1A4 activity, likely involving steroid receptor interactions. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Capsaicin may activate UGT1A4 by altering metabolic pathways, although the exact mechanism is not fully understood. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone activates UGT1A4 by glucocorticoid receptor-mediated induction of gene expression. | ||||||